US20220233837A1 - An antimicrobial device for an insertion needle - Google Patents

An antimicrobial device for an insertion needle Download PDF

Info

Publication number
US20220233837A1
US20220233837A1 US17/629,094 US202017629094A US2022233837A1 US 20220233837 A1 US20220233837 A1 US 20220233837A1 US 202017629094 A US202017629094 A US 202017629094A US 2022233837 A1 US2022233837 A1 US 2022233837A1
Authority
US
United States
Prior art keywords
dressing
contact
insertion needle
adhesive
cover
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
US17/629,094
Other languages
English (en)
Inventor
Joseph M. Hommes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Solventum Intellectual Properties Co
Original Assignee
3M Innovative Properties Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3M Innovative Properties Co filed Critical 3M Innovative Properties Co
Priority to US17/629,094 priority Critical patent/US20220233837A1/en
Assigned to 3M INNOVATIVE PROPERTIES COMPANY reassignment 3M INNOVATIVE PROPERTIES COMPANY ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: HOMMES, JOSEPH M.
Publication of US20220233837A1 publication Critical patent/US20220233837A1/en
Assigned to SOLVENTUM INTELLECTUAL PROPERTIES COMPANY reassignment SOLVENTUM INTELLECTUAL PROPERTIES COMPANY ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: 3M INNOVATIVE PROPERTIES COMPANY
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/02—Access sites
    • A61M39/0247—Semi-permanent or permanent transcutaneous or percutaneous access sites to the inside of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
    • A61M5/14248—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body of the skin patch type
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00361—Plasters
    • A61F2013/00365—Plasters use
    • A61F2013/00412—Plasters use for use with needles, tubes or catheters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00361—Plasters
    • A61F2013/00365—Plasters use
    • A61F2013/00412—Plasters use for use with needles, tubes or catheters
    • A61F2013/00417—Plasters use for use with needles, tubes or catheters pierced by needle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00361—Plasters
    • A61F2013/00655—Plasters adhesive
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00361—Plasters
    • A61F2013/00795—Plasters special helping devices
    • A61F2013/00825—Plasters special helping devices protection of wound surround
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/158—Needles for infusions; Accessories therefor, e.g. for inserting infusion needles, or for holding them on the body
    • A61M2005/1586—Holding accessories for holding infusion needles on the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/02—Access sites
    • A61M39/0247—Semi-permanent or permanent transcutaneous or percutaneous access sites to the inside of the body
    • A61M2039/0258—Semi-permanent or permanent transcutaneous or percutaneous access sites to the inside of the body for vascular access, e.g. blood stream access
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/02—Access sites
    • A61M39/0247—Semi-permanent or permanent transcutaneous or percutaneous access sites to the inside of the body
    • A61M2039/0276—Semi-permanent or permanent transcutaneous or percutaneous access sites to the inside of the body for introducing or removing fluids into or out of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/02—Access sites
    • A61M39/0247—Semi-permanent or permanent transcutaneous or percutaneous access sites to the inside of the body
    • A61M2039/0285—Semi-permanent or permanent transcutaneous or percutaneous access sites to the inside of the body with sterilisation means, e.g. antibacterial coatings, disinfecting pads, UV radiation LEDs or heating means in the port
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/02—Access sites
    • A61M39/0247—Semi-permanent or permanent transcutaneous or percutaneous access sites to the inside of the body
    • A61M2039/0288—Semi-permanent or permanent transcutaneous or percutaneous access sites to the inside of the body protectors, caps or covers therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/02—General characteristics of the apparatus characterised by a particular materials
    • A61M2205/0205—Materials having antiseptic or antimicrobial properties, e.g. silver compounds, rubber with sterilising agent

Definitions

  • the present disclosure relates to an antimicrobial device.
  • the present disclosure relates to an antimicrobial device, a kit with an insertion device and an antimicrobial contact dressing, and a process of providing an antimicrobial agent around an insertion device.
  • percutaneous devices pass through skin for a variety of functions, such as fluid delivery or medical device support.
  • percutaneous devices used to administer medication, such as, for example, a diabetic pump or a Huber needle, which might also include an implanted port.
  • Some of these devices may be connected for an extended period of time causing irritation or discomfort on the skin and increasing the risks of infection at the injection site.
  • the disclosed antimicrobial device has a contact dressing with both adhesive and antimicrobial agent on the contact dressing surface to securely attaches to an underlying substrate and the insertion needle punctures though the contact dressing.
  • the contact adhesive and the antimicrobial agent remain adjacent to the inserted needle.
  • the antimicrobial device comprises a contact dressing with a contact dressing first surface and contact dressing second surface, opposite the contact dressing first surface.
  • the contact dressing first surface has an adhesive and an antimicrobial agent.
  • the insertion needle is inserted through the contact dressing.
  • the adhesive and antimicrobial agent are on the contact dressing first surface adjacent the inserted insertion needle.
  • FIG. 1 is a side sectional view of one embodiment of an antimicrobial device
  • FIG. 2 is a plan view of one embodiment of a first contact dressing surface
  • FIG. 3 is a plan view of another embodiment of a first contact dressing surface
  • a conventional device to providing antimicrobial protection to an insertion needle is a disk-shaped sponge loaded with an antimicrobial agent, commercially available as BiopatchTM protective disk available from Ethicon.
  • an antimicrobial agent commercially available as BiopatchTM protective disk available from Ethicon.
  • the tube or insertion needled is first threaded through the opening of the disk, and then the insertion needle is inserted into the substrate, typically skin. This requires two hands working together to thread the insertion needle through the disk.
  • the disk-shaped device is not transparent. Therefore, the disk-shaped device must be removed to view the area around the insertion needle for signs of infection.
  • Another device that provides antimicrobial protection to an insertion needle is 3M Tegaderm CHG dressing, which includes a gel pad loaded with chlorhexidine gluconate. For this device, the needle is inserted and the gel pad is placed over the inserted needle.
  • the disclosed antimicrobial device 100 has an antimicrobial contact dressing 110 that securely attaches to an underlying substrate 140 .
  • the antimicrobial contact dressing 110 has a surface with an adhesive 114 and an antimicrobial agent 115 .
  • An insertion needle 134 can puncture though the antimicrobial contact dressing 110 for easy application and antimicrobial protection of the insertion needle 134 .
  • the adhesive 114 and antimicrobial agent 115 are adjacent to the inserted needle 134 .
  • the adhesive 114 maintains the contact dressing 110 securely in place to the underlying substrate 140 follow insertion of the insertion needle 134 , and the antimicrobial agent 115 also being adjacent to the insertion needle 134 maintains antimicrobial efficacy to the area around the insertion needle 115 .
  • FIG. 1 is a side sectional view of one embodiment of an antimicrobial device 100 .
  • the antimicrobial device has a contact dressing 110 that secures to an underlying substrate 140 .
  • the contact dressing 110 has a contact dressing first surface 112 with an adhesive 114 and antimicrobial agent 115 .
  • the adhesive 114 on the contact dressing first surface 112 secures the contact dressing 110 to the underlying substrate 140 .
  • Opposite from the contact dressing first surface 112 is the contact dressing second surface 116 .
  • the contact dressing 110 is a thin, flexible, conformable material with one or more layers, such as a film, paper, foil, woven, knitted, or nonwoven.
  • An access needle hub 130 includes a housing 132 and insertion needle 134 .
  • the housing 132 is adjacent to the contact dressing second surface 116 .
  • the insertion needle 134 punctures through the contact dressing 110 and into the substrate 140 .
  • underlying the substrate 140 may be an access port 150 for receiving the insertion needle 134 and aligning with the housing 132 .
  • the access needle hub 130 can be used to deliver fluid through the insertion needle 134 and into the substrate 140 and/or can be used to remove fluid from the underlying substrate 140 .
  • the fluid flow through the access needle hub 130 could be a one-time delivery of fluid or could be continuously delivered.
  • the contact dressing first surface 112 is applied to a substrate 140 .
  • the access needle hub 130 is placed over the contact dressing second surface 116 .
  • the insertion needle 134 passes through the contact dressing 110 .
  • the insertion needle 134 is protruding from the housing 130 and punctures though the contact dressing 110 as the access needle hub 130 comes into contact with the contact dressing second surface 110 .
  • the insertion needle 134 can be linear or slightly curved at the end.
  • a linear insertion needle 134 often referred to as a non-coring needle, will tend to create a punch hole in the contact dressing 110 .
  • the insertion needle 134 will slice through the contact dressing 110 and will tend to create a linear slit 118 in the contact dressing 110 .
  • the insertion needle 134 is retracted within the housing 132 and as the access needle hub 130 comes into contact with the contact dressing second surface 116 the insertion needle 134 is actuated to release from within the housing 132 .
  • the insertion needle 134 can linearly projected out of the housing 132 and into the substrate 140 .
  • the insertion needle 134 can be either linear or slightly curved at the end. Linearly projecting the linear insertion needle 134 from the housing 140 will tend to create a punch hole in the contact dressing 110 . Linearly projecting a slightly curved insertion needle 134 will tend to slice through the contact dressing 110 to create a slit 118 .
  • the insertion needle 134 will rotationally project out of the housing 132 , pass through the contact dressing 110 , and enter into the substrate 140 .
  • the rotational projection of the insertion needle 134 from the housing 132 will tend to create a linear slit 118 in the contact dressing 110 .
  • the antimicrobial device 100 with the contact dressing 110 and an overlying access needle hub 130 that punctures through the contact dressing 118 to form a slit 118 can be advantageous over insertion needles 134 that puncture straight linearly.
  • insertion needles 134 that puncture straight linearly.
  • the adhesive 114 and antimicrobial agent 115 are included at least in the area surrounding the insertion needle 134 and with both the adhesive and the antimicrobial agent 115 in contact with the substrate 140 .
  • the adhesive 114 and antimicrobial agent 115 may be applied to the contact dressing first surface 112 separately and adjacent to one another or the antimicrobial agent 115 is loaded into the adhesive 114 .
  • the adhesive 114 secures the contact dressing 110 to the substrate 140 . Then during and after the insertion needle 134 punctures through the contact dressing 110 , the adhesive 114 maintains the contact dressing 110 in contact with the substrate 140 . Therefore, the contact dressing 110 does not become loose or able to be dislodges and inadvertently enter into the substrate 140 . Especially in embodiments of a non coring insertion needle 134 where a slit 118 is formed through the contact dressing 110 , the contact dressing 110 will tend to widen at the slit 118 and the underlying adhesive 114 on the contact dressing 110 will maintain secure connection of the contact dressing first surface 112 at the slit 118 .
  • the antimicrobial agent 115 is present at least in the area surrounding the insertion needle 134 , the antimicrobial agent 115 is present at the interface of the insertion needle 134 and substrate 140 to aid in minimizing contamination and reducing the risk of infection.
  • an optional cover dressing 120 can be used to aid in securing the access needle hub 130 .
  • the cover dressing 120 has a cover dressing first surface 122 and an opposite cover dressing second surface 126 .
  • the cover dressing first surface 122 has a cover dressing adhesive 124 to allow the cover dressing to secure to the underlying access needle hub 130 , the contact dressing second surface 116 , and/or to the substrate 140 .
  • FIG. 2 is a plan view of one embodiment of a contact dressing first surface 112 showing the insertion needle 134 , which has formed a slit 118 though the contact dressing first surface 112 .
  • the adhesive 114 and antimicrobial agent 115 are located adjacent to the slit 118 and adjacent to the insertion needle 134 .
  • the adhesive 114 is distinct from the antimicrobial agent 115 .
  • each of the adhesive 114 and the antimicrobial agent 115 is applied in a pattern and separate from one another.
  • the perimeter region comprises the adhesive 114 , and does not include the antimicrobial agent 115 .
  • FIG. 3 is a plan view of one embodiment of a contact dressing first surface 112 showing the insertion needle 134 , which has formed a slit 118 though the contact dressing first surface 112 .
  • the adhesive 114 and antimicrobial agent 115 are located adjacent to the slit 118 and adjacent to the insertion needle 134 .
  • the antimicrobial agent 115 is dispersed throughout the adhesive 114 .
  • the antimicrobial-containing adhesive 114 is uniformly applied over the contact dressing first surface 112 .
  • the antimicrobial-containing adhesive 114 may be applied discontinuously, such as in a pattern on the contact dressing first surface 112 .
  • the antimicrobial device 100 may be provided to a health care provider in a kit with a access needle hub 130 .
  • a cover dressing and tape can be included in the kit.
  • skin antiseptic materials can be included in the kit to clean the skin prior to application of the contact dressing 110 .
  • gloves or masks can be provided in the kits for the health care provider to wear while applying the contact dressing and inserting the access needle hub.
  • components in the kit are sterile or the entire kit is sterilized.
  • the contact dressing 110 and cover dressing 120 are typically thin film materials, coated with the adhesive.
  • the thin film material provides resistance against incoming water and contaminants and has a high moisture vapor permeability to allow moisture vapor from the underlying skin to exit.
  • a suitable material is a high moisture vapor permeable film such as described in U.S. Pat. Nos. 3,645,835 and 4,595,001, the disclosures of which are herein incorporated by reference. Issued U.S. Pat. Nos. 3,645,835 and 4,595,001, the disclosures of which are hereby incorporated by reference, describe methods of making such films and methods for testing their permeability.
  • the film/adhesive composite should transmit moisture vapor at a rate equal to or greater than human skin.
  • the adhesive coated film transmits moisture vapor at a rate of at least 300 g/m 2 /24 hrs/37° C./100-10% RH, more preferably at least 700 g/m 2 /24 hrs/37° C./100-10% RH, and most preferably at least 2000 g/m 2 /24 hrs/37° C./100-10% RH using the inverted cup method as described in U.S. Pat. No. 4,595,001.
  • the material for the dressing is preferably conformable to anatomical surfaces. As such, when applied to an anatomical surface, it conforms to the surface even when the surface is moved and can stretch and retract.
  • a film is elastomeric polyurethane, polyester, or polyether block amide films. These films combine the desirable properties of resiliency, high moisture vapor permeability, and transparency.
  • Example of material for the thin film dressing is in 3M Tegaderm IV Dressings available from 3M Company.
  • U.S. Patent application 62/783,368, filed Dec. 21, 2018 describes a medical article with backing that may be suitable as the contact dressing.
  • Additional materials can be included with the thin film to give the dressing strength, rigidity.
  • woven, knitted, nonwoven, or polymeric material can be included.
  • US Patent Application Publication US 2016-0015570 Examples of multilayer constructions for a dressing is in 3M Tegaderm IV Advanced Dressings, available from 3M Company.
  • thin film dressing typically includes a frame.
  • the frame is made of a substrate that is less resilient than the film and may be removable from the film. Examples of materials and frames include those in 3M Tegaderm IV Dressings and 3M Tegaderm IV Advanced Dressings, both available from 3M Company.
  • the contact dressing first surface 112 contains an antimicrobial agent 115 to deliver antimicrobial activity to the skin in and around the injection site, reducing the likelihood of an infection.
  • an antimicrobial agent 115 to deliver antimicrobial activity to the skin in and around the injection site, reducing the likelihood of an infection.
  • the antimicrobial agent 115 can be applied directly to the contact dressing first surface 112 adjacent to the adhesive 114 or may be incorporated into the adhesive 114 . In some embodiments, the antimicrobial agent 115 may be applied in a pattern. Also, the antimicrobial agent 115 may be applied to the entire contact dressing first surface.
  • antimicrobial agents include parachlorometaxylenol; triclosan; chlorhexidine and its salts such as chlorhexidine gluconate, poly hexamethylene biguanide and its salts such as poly hexamethylene biguanidine chloride, iodine, idodophors; fatty acid monoesters; poly-n-vinyl pyrrolidone-iodophors; silver oxide, silver and its salts, peroxides (e.g. hydrogen peroxide), antibiotics (e.g. neomycin, bacitracin, and polymixin B).
  • chlorhexidine and its salts such as chlorhexidine gluconate, poly hexamethylene biguanide and its salts such as poly hexamethylene biguanidine chloride, iodine, idodophors; fatty acid monoesters; poly-n-vinyl pyrrolidone-iodophors; silver
  • active ingredients could also be used to suppress the regrowth or possibly treat an infection of microorganisms in the present invention: 2,2-thiobis(4-chlorophenol); 4,4-isopropylidenediphenol; 5-amino-6-chloro-o-cresol; acetaminosalol; alcloxa; aldioxa; aluminum acetate; aluminum benzoate; aluminum diacetate; aluminum formate; aluminum phenolsulfonate; ammonium iodide; ammonium phenolsulfonate; benzisothiazolinone; benzotriazole; benzoxiquine; benzylparaben; berberine chloride; boric acid; cetethyl morpholinium ethosulfate; cetethyldimonium bromide; cetrimonium tosylate; cetylpyridinium chloride; chloramine-t; chlorothymol; cloflucarban; cocotrimonium chloride; colloidal sulfur;
  • the following actives could also be of use to also reduce regrowth of microorganisms on skin: 2-bromo-2-nitropropane-1,3-diol; 4-hydroxybenzoic acid; 5-bromo-5-nitro-1,3-dioxane; 7-ethylbicyclooxazolidine; ammonium benzoate; ammonium bisulfate; ammonium propionate; ammonium sulfite; behentrimonium chloride; benzalkonium bromide; benzalkonium chloride; benzalkonium saccharinate; benzethonium chloride; benzoic acid; benzyl alcohol; benzylhemiformal; bromochlorophene; butyl benzoate; butylparaben; calcium benzoate; calcium paraben; calcium propionate; calcium salicylate; calcium sorbate; calcium undecylenate; cetalkonium chloride; cetearalkonium bromide; cetrimonium bromid
  • the adhesive used on the contact dressing and/or cover dressing is typically a pressure sensitive adhesive, such as an acrylate-based adhesive.
  • the pressure sensitive adhesives described above typically transmit moisture vapor at a rate greater to or equal to that of human skin.
  • a pressure sensitive acrylate adhesive that can be applied to skin is described in U.S. Pat. No. RE 24,906, the disclosure of which is hereby incorporated by reference.
  • a 97:3 iso-octyl acrylate:acrylamide copolymer adhesive can be used or a 70:15:15 isooctyl acrylate: ethyleneoxide acrylate:acrylic acid terpolymer, as described in U.S. Pat. No. 4,737,410 (Example 31), the disclosure of which is hereby incorporated by reference.
  • Other useful adhesives are described in U.S. Pat. Nos.
  • Silicone adhesive can also be used. Generally, silicone adhesives can provide suitable adhesion to skin while gently removing from skin. Suitable silicone adhesives are disclosed in PCT Publications WO2010/056541 and WO2010/056543, the disclosure of which are herein incorporate by reference.
  • the adhesive 114 can be applied directly to the contact dressing first surface 112 adjacent to the antimicrobial agent 115 or the antimicrobial agent 115 may be incorporated into the adhesive 114 .
  • the adhesive may be applied in a pattern, as described in U.S. Pat. No. 4,595,001 which is hereby incorporated by reference. Also, it is understood that the entire surface may include adhesive or the adhesive may be at select portions.
  • a release liner maybe used to cover the adhesive. During use, the release liner is removed, exposing the adhesive.
  • Release liners can be made of paper or films, such as kraft papers, polyethylene, polypropylene, polyester or composites of any of these materials. The release liners are typically coated with release agents such as fluorochemicals or silicones.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Materials For Medical Uses (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicinal Preparation (AREA)
US17/629,094 2019-08-01 2020-07-13 An antimicrobial device for an insertion needle Pending US20220233837A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US17/629,094 US20220233837A1 (en) 2019-08-01 2020-07-13 An antimicrobial device for an insertion needle

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962881650P 2019-08-01 2019-08-01
US17/629,094 US20220233837A1 (en) 2019-08-01 2020-07-13 An antimicrobial device for an insertion needle
PCT/IB2020/056565 WO2021019339A1 (en) 2019-08-01 2020-07-13 An antimicrobial device for an insertion needle

Publications (1)

Publication Number Publication Date
US20220233837A1 true US20220233837A1 (en) 2022-07-28

Family

ID=71728828

Family Applications (1)

Application Number Title Priority Date Filing Date
US17/629,094 Pending US20220233837A1 (en) 2019-08-01 2020-07-13 An antimicrobial device for an insertion needle

Country Status (5)

Country Link
US (1) US20220233837A1 (https=)
EP (1) EP4007621A1 (https=)
JP (1) JP2022543769A (https=)
CN (1) CN114173727A (https=)
WO (1) WO2021019339A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220193335A1 (en) * 2020-12-22 2022-06-23 Sonia Brunner Intravenous Cuff Assembly

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202100006284A1 (it) * 2021-03-16 2022-09-16 U Earth Biotech Ltd Mezzi di filtraggio di una maschera facciale indossabile
US20250082846A1 (en) * 2022-01-10 2025-03-13 Shl Medical Ag Adhesive pad

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3783868A (en) * 1971-05-06 1974-01-08 Gulf Oil Corp Percutaneous implant
US5738641A (en) * 1996-07-31 1998-04-14 Watson; Robert L. Blood withdrawal patch
US7129389B1 (en) * 2002-10-29 2006-10-31 Robert Watson Puncture site patch
US10286159B2 (en) * 2017-09-07 2019-05-14 URO-1, Inc. Medical injection assemblies for onabotulinumtoxina delivery and methods of use thereof
US10434284B2 (en) * 2012-12-21 2019-10-08 3M Innovative Properties Company Medical dressing comprising a flap
US10898644B2 (en) * 2011-03-30 2021-01-26 Uno Medical A/S Subcutaneous inserter device
US20210308380A1 (en) * 2018-07-24 2021-10-07 Antares Pharma, Inc. Injector

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA677797A (en) 1955-11-18 1964-01-14 Minnesota Mining And Manufacturing Company Sheet material having a pressure-sensitive adhesive coating of acrylate ester copolymer
US4112213A (en) 1964-09-28 1978-09-05 Johnson & Johnson Pressure sensitive adhesive tapes and method of making same
US3389827A (en) 1967-04-10 1968-06-25 Minnesota Mining & Mfg Easy-open container and sealing tape
NO134790C (no) 1968-07-09 1984-03-22 Smith & Nephew Klebende,; trykkfoelsomt, vanndamp-permeabelt produkt for bruk paa hud hos mennesker.
US4310509A (en) 1979-07-31 1982-01-12 Minnesota Mining And Manufacturing Company Pressure-sensitive adhesive having a broad spectrum antimicrobial therein
US4323557A (en) 1979-07-31 1982-04-06 Minnesota Mining & Manufacturing Company Pressure-sensitive adhesive containing iodine
AU560088B2 (en) 1982-04-08 1987-03-26 Smith & Nephew Associated Companies Plc Surgical adhesive dressing
US4737410A (en) 1986-11-28 1988-04-12 Minnesota Mining And Manufacturing Company Polyalkyloxazoline-reinforced acrylic pressure-sensitive adhesive composition
US5829442A (en) * 1996-06-12 1998-11-03 Medical Concepts Development, Inc. Antimicrobial containing solventless hot melt adhesive composition
US7137968B1 (en) * 2000-03-13 2006-11-21 Nucryst Pharmaceuticals Corp. Transcutaneous medical device dressings and method of use
AU2006270308A1 (en) * 2005-07-15 2007-01-25 Covidien Lp Wound dressing and methods of making and using the same
JP5662329B2 (ja) 2008-10-29 2015-01-28 スリーエム イノベイティブ プロパティズ カンパニー 電子ビーム硬化シリコーン材料
JP5868177B2 (ja) 2008-10-29 2016-02-24 スリーエム イノベイティブ プロパティズ カンパニー 電子ビーム硬化される非官能化シリコーン感圧接着剤
US9566417B1 (en) * 2009-07-02 2017-02-14 Centurion Medical Products Corporation Integrated antimicrobial dressing
US8969649B2 (en) * 2012-08-10 2015-03-03 Ethicon, Inc. Integrated dressing device
WO2014035971A2 (en) 2012-08-28 2014-03-06 3M Innovative Properties Company Chlorhexidine gluconate solubilized in a hydrophobic monoacylglyceride
CA2883373A1 (en) 2012-08-28 2014-03-06 3M Innovative Properties Company Chlorhexidine gluconate compositions, resin systems and articles
WO2014039891A2 (en) * 2012-09-07 2014-03-13 C. R. Bard, Inc. Medical article securement systems
US9629983B2 (en) * 2013-03-08 2017-04-25 Ethicon, Inc. All in one antimicrobial dressing for catheter coverage
WO2014149718A1 (en) 2013-03-11 2014-09-25 3M Innovative Properties Company A conformable medical dressing
WO2018067758A1 (en) * 2016-10-07 2018-04-12 3M Innovative Properties Company Conformable wound dressing and delivery system

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3783868A (en) * 1971-05-06 1974-01-08 Gulf Oil Corp Percutaneous implant
US5738641A (en) * 1996-07-31 1998-04-14 Watson; Robert L. Blood withdrawal patch
US7129389B1 (en) * 2002-10-29 2006-10-31 Robert Watson Puncture site patch
US10898644B2 (en) * 2011-03-30 2021-01-26 Uno Medical A/S Subcutaneous inserter device
US10434284B2 (en) * 2012-12-21 2019-10-08 3M Innovative Properties Company Medical dressing comprising a flap
US10286159B2 (en) * 2017-09-07 2019-05-14 URO-1, Inc. Medical injection assemblies for onabotulinumtoxina delivery and methods of use thereof
US20210308380A1 (en) * 2018-07-24 2021-10-07 Antares Pharma, Inc. Injector

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220193335A1 (en) * 2020-12-22 2022-06-23 Sonia Brunner Intravenous Cuff Assembly
US11833324B2 (en) * 2020-12-22 2023-12-05 Sonia Brunner Intravenous cuff assembly

Also Published As

Publication number Publication date
EP4007621A1 (en) 2022-06-08
CN114173727A (zh) 2022-03-11
WO2021019339A1 (en) 2021-02-04
JP2022543769A (ja) 2022-10-14

Similar Documents

Publication Publication Date Title
US9572942B2 (en) Medical dressing comprising an apertured hydrogel
US20220233837A1 (en) An antimicrobial device for an insertion needle
CN104540485B (zh) 一体式敷料装置
US20220265893A1 (en) Wound care device having fluid transfer and adhesive properties
US12343435B2 (en) Wound care device having fluid transfer and adhesive properties
US9629983B2 (en) All in one antimicrobial dressing for catheter coverage
JP6373832B2 (ja) 複数の接着剤を有する医療用手当て用品
US20200000640A1 (en) Multi-Layer Wound Care Device Having Absorption and Fluid Transfer Properties
US20210308318A1 (en) Wound dressing system
JP5092105B2 (ja) カテーテル固定具及びカテーテル固定具用パッド
JP2008183244A (ja) カテーテル固定具
US11723812B2 (en) Organic cotton surface nursing pad
KR200412665Y1 (ko) 지혈용 1회용 테이프
CN210843649U (zh) 一种外科手术刀口恢复护理装置
US20060015055A1 (en) Air permeable tape
KR200394389Y1 (ko) 지혈용 1회용 테이프
US20210298294A1 (en) Cough patch with germicidal and/or antimicrobial properties
CN206534947U (zh) 一种水胶体输液贴
BR102015022642A2 (pt) absorvente e arranjo para tecido de roupa veterinária junto a cortes cirúrgicos de animais, com sistema de inserção e retirada

Legal Events

Date Code Title Description
AS Assignment

Owner name: 3M INNOVATIVE PROPERTIES COMPANY, MINNESOTA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:HOMMES, JOSEPH M.;REEL/FRAME:058724/0802

Effective date: 20210325

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

AS Assignment

Owner name: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY, MINNESOTA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:3M INNOVATIVE PROPERTIES COMPANY;REEL/FRAME:066430/0149

Effective date: 20240201

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION COUNTED, NOT YET MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION